Amicus Therapeutics
Amicus Therapeutics raises $60 million in series D financing
Published in Genetics and Environmental Business Week, October 19th, 2006
In August, due to market conditions, the company withdrew its S-1 registration statement with the Securities and Exchange Commission (SEC) relating to a proposed initial public offering.
In this financing round, NEA was joined by current investors Canaan Partners, CHL Medical Partners, Frazier Healthcare Ventures, Palo Alto Investors, Prospect...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Business Week
More Articles from Genetics and Environmental Business Week
- Elekta
Elekta reports proceedings of Annual General Meeting 2006 - Aichi Cancer Center, Aichi, Japan
Findings from Japan advance knowledge in lung cancer research - Alba Therapeutics
Alba initiates phase II trial for Zonulin antagonist AT-1001 for autoimmune disorder - Albert & Mary Lasker Foundation, U.S.
Three U.S. scientists win Lasker Award for basic medical research - Alexandra Hospital, Singapore, Singapore
Single nucleotide polymorphisms do not indicate increased diabetes nephropathy risk - All India Institute of Medical Sciences, India
New findings from India, Greece and the United Kingdom in the area of tuberculosis described - More from this issue of Genetics and Environmental Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
